Zimmer Biomet (ZBH) PT Raised to $155 at Stifel After Orthopedic Procedures Rebound
Tweet Send to a Friend
Stifel analyst Rick Wise raised the price target on Zimmer Biomet (NYSE: ZBH) to $155.00 (from $130.00) after 2Q20 results ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
